Sunday, January 15, 2017

Orlistat To Lower Cholesterol

Orlistat has been approved by the Food and Drug Administration to help people lose weight. Although the weight loss is not very great, it has far greater potential to help lower cholesterol and prevent heart attacks. Orlistat blocks enzymes that help you absorb fat, so that only 2/3rds of fat in the intestines is absorbed, while 1/3d will pass from your body and can cause bloating, cramping and fatty leakage (1,2). It also can rob you of fat-soluble vitamins, ADE and K. You can prevent these side effects by severely restricting your intake of fat and taking extra vitamins A,D and E by eating huge amounts of yellow, orange and green vegetables, and whole grains, beans, seeds and nuts instead of bakery products, and by exposing your skin to sunlight on a regular basis.

In one study, people who took Orlistat plus a low fat diet lost 19.3 pounds, while those who only dieted lost 12.8 pounds. I do not believe that this minimal weight loss is worth the $3.30 per day that the manufacturer will charge. The manufacturer, Roche, has already done studies showing that the combination of cholesterol lowering drugs plus Orlistat is safe and highly effective in lowering cholesterol (3).
1) CY Oo, B Akbari, S Lee, G Nichols, CP Hellmann.Effect of orlistat, a novel anti-obesity agent, on the pharmacokinetics and pharmacodynamics of pravastatin in patients with mild hypercholesterolaemia. Clinical Drug Investigation, 1999, Vol 17, Iss 3, pp 217-223. Roche .

2)JB Harp. Orlistat for the long-term treatment of obesity. Drugs of Today, 1999, Vol 35, Iss 2, pp 139-145.

3)JB Harp. Orlistat for the long-term treatment of obesity. Drugs of Today, 1999, Vol 35, Iss 2, pp 139-145.

4)JO Hill, J Hauptman, JW Anderson, K Fujioka, PM ONeil, DK Smith, JH Zavoral, LJ Aronne. rlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. American Journal of Clinical Nutrition, 1999, Vol 69, Iss 6, pp 1108-1116.


Orlistat FDA OTC Approved Weight Loss Aid Also Appears to Prevent the Onset of Type 2 Diabetes


Thursday, January 12, 2017


Heartburn medication can up your risk of hospitalization by 70%

People who use commonly-prescribed heartburn medication are 70 per cent more likely to be admitted to hospital for infectious gastroenteritis, new research has shown.
Proton pump inhibitors, or PPIs, are one of the world’s most commonly used gastric acid suppressants, with more than 19 million scripts prescribed each year in Australia.
A study led by the Australian National University has found people who use the medication are much more likely to be hospitalised for gastro.